NGVT vs TECH · rev $1.41B vs P/E 65, rev $1.22B
Ingevity Corp (NGVT) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
Ingevity Corp (NGVT) is a specialty chemicals company listed on NYSE.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported NGVT revenue for 2024-12-31 was $1.41B. Net income was -$430.3M. Revenue was down 16.9% from 2023-12-31 to 2024-12-31. NGVT currently screens at market cap $2.52B.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
NGVT currently screens at market cap $2.52B. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the NGVT and TECH stock pages for the full models.
Not investment advice.